Clinical Trial Update: Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating stereotactic brain-directed radiation with or without Aguix gadolinium-based nanoparticles for brain metastases; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Brain Metastases
• Breast Cancer
• Colorectal Cancer
• Gastrointestinal Cancer
• Lung Cancer
• Melanoma

Drugs mentioned

• AGuIX

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Brain Cancer, Brain Metastases | Phase 2 | Status: ACTIVE_NOT_RECRUITING